SAN DIEGO – The pharmaceutical industry likely will remain dependent on worldwide operations despite rising political opposition to globalization, US Food and Drug Administration Commissioner Robert Califf said, which necessitates continued coordination with foreign regulators.
Key Takeaways
-
Supply chains already are connected and likely will stay that way despite the push against globalization, Califf said.
-
International regulatory coordination, such as ICMRA, will have to adapt to the different political attitudes
“We’re interdigitated whether people like it or not,” Califf said 19 June during the DIA Global Annual
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?